fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

EMA Highlights: EMA gives green light for infant tumour drug

Written by | 24 Mar 2014

by Gary Finnegan – The European drug regulator has given a paediatric-use marketing authorisation (PUMA) for Hemangiol to treat proliferation of infantile haemangioma.

​Mind over matter: Beating pain and painkillers – Mindfulness reduces pain and opioid misuse

Written by | 4 Mar 2014

University of Utah researcher Eric Garland (pictured) developed a new mindfulness-focused treatment for people with chronic pain that can effectively reduce pain and misuse of opioid painkillers.

New drug reduces chronic pain in shingles

Written by | 3 Mar 2014

A new drug treatment has been found to be effective against chronic pain caused by nerve damage, also known as neuropathic pain, in patients who have had shingles.

New pain target for bacterial infections

Written by | 28 Feb 2014

Components in the outer wall of bacteria directly activate pain sensors, triggering immediate pain and inflammatory responses. This finding by a multinational team sheds new light on pain… read more.

Sedation before nerve block increases risk, not pain relief

Written by | 27 Feb 2014

New research suggests that sedating patients before a nerve block needed to diagnose or treat chronic pain increases costs, risks and unnecessary surgeries, and sedation does nothing to… read more.

Restless sleep cause pain in elderly?

Written by | 26 Feb 2014

Researchers in the U.K. report that non-restorative sleep is the strongest, independent predictor of widespread pain onset among adults over the age of 50.

Breastfeeding reduce pain in preterms?

Written by | 25 Feb 2014

Effects evaluated in new study published in PAIN.  Poorly managed pain in the neonatal intensive care unit has serious short- and long-term consequences, causing physiological and behavioural instability… read more.

Buprenorphine effective in all elderly age groups

Written by | 21 Feb 2014

A recent pharmacokinetic study with buprenorphine transdermal patches showed similar systemic exposures of buprenorphine in subjects aged 75 and 50–60 years. The current prospective, open-label study aimed to… read more.

Cell therapy shows ability to fight cancer

Written by | 19 Feb 2014

Genetically modified T cells induced complete remissions in 88 percent of advanced leukemia patients treated.  Investigators have reported more encouraging news about one of the most exciting methods… read more.

Caffeine use disorder: A widespread health problem that needs more attention

Written by | 11 Feb 2014

Caffeine is the most widely used drug, but little is known about helping those who depend on it.  “I’m a zombie without my morning coffee.” “My blood type… read more.

Press Release: Emerging data from CLL10 presented at ASH suggests Levact® (bendamustine) and rituximab as new treatment option for fit elderly CLL patients

Written by | 7 Feb 2014

New interim analysis study findings presented for the first time today at the 55th American Society of Hematology (ASH) Annual Meeting in New Orleans suggest bendamustine and rituximab… read more.

Vitamin D supplementation reduces pain in Fibromyalgia

Written by | 30 Jan 2014

by Bruce Sylvester – Fibromyalgia syndrome (FMS) patients with low vitamin D can reduce pain by taking supplements, and possibly lower the costs of other drug and non-drug… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.